Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-06-15
Analyst
Jeffery's
Equibles does not estimate personal net worth.
Miyabi Yamakita is recorded as Analyst at Jeffery's. Miyabi Yamakita has spoken on 1 investor event across 1 company, most recently for Nxera Pharma Co., Ltd. on June 15, 2026. The companies whose calls Miyabi Yamakita spoke on are classified in the Healthcare sector.
“I cover Japan biotech companies at Jeffery's in Tokyo. In this fireside session, we have the next server, represented by CEO Chris Kageo and CFO Hironoshin Nomura.”
Jeffery's
Analyst
Transcript header (unverified)
Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
Jefferies Global Healthcare Conference
Nxera Pharma Co., Ltd.